ResearcherUniversidade do PortoNo recent work listed
Sílvia Castro Coelho
Matched on ORCID iD 0000-0002-9985-3358; OpenAlex author ID A5082622857. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 1 paper
Papers 4
- Doxorubicin and Varlitinib Delivery by Functionalized Gold Nanoparticles Against Human Pancreatic Adenocarcinoma. Co-author DOI 10.3390/pharmaceutics11110551↗
- Gold Nanoparticles for Targeting Varlitinib to Human Pancreatic Cancer Cells. Co-author DOI 10.3390/pharmaceutics10030091↗
- Development of Parvifloron D-loaded Smart Nanoparticles to Target Pancreatic Cancer. Co-author DOI 10.3390/pharmaceutics10040216↗
- Enhancing the efficiency of bortezomib conjugated to pegylated gold nanoparticles: an in vitro study on human pancreatic cancer cells and adenocarcinoma human … Co-author DOI 10.1080/17425247.2016.1178234↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Manuel A. N. Coelho · 4 shared papers, 2016–2019 · strength 0.40
- Paper Doxorubicin and Varlitinib Delivery by Functionalized Gold Nanoparticles Against Human Pancreatic Adenocarcinoma. DOI 10.3390/pharmaceutics11110551↗
- Paper Gold Nanoparticles for Targeting Varlitinib to Human Pancreatic Cancer Cells. DOI 10.3390/pharmaceutics10030091↗
- Paper Enhancing the efficiency of bortezomib conjugated to pegylated gold nanoparticles: an in vitro study on human pancreati… DOI 10.1080/17425247.2016.1178234↗
- Ana Santos-Rebelo · 1 shared paper, 2018 · strength 0.07
- Catarina Pinto Reis · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.